ESG Report 2021

Against the backdrop of increasing support which the R&D laboratory is approximately 2 for the bio-pharmaceutical industry by the 1,600 m , including new drug R&D laboratory, state and the Guangdong-Hong Kong-Macao drug screening platform laboratory, cell Greater Bay Area, the Group has established a research laboratory, process development bio-pharmaceutical research and development research laboratory and quality control headquarters, The United Bio-Technology laboratory. After the implementation of the (Hengqin) Co., Ltd. ( project, about 60 high-end talents joined the ) in the Guangdong-Macao project for scientific research. On the basis of Cooperative Traditional Chinese Medicine the existing technology and research team of Technology Industrial Park ( Hengqin TCM some marketed products, the Company Industrial Park ) in Hengqin New Area, Zhuhai. expanded the introduction of talents in Located in Hengqin TCM Industrial Park, a biological investment and biological R&D, national pharmaceutical industrial park, deepened and expanded its development in will create a first-class the fields of diabetes drugs, monoclonal R&D and service platform integrating antibody drugs, chronic disease management, s c i e nt i f i c re s e a rc h , a c adem i c and cooperation with scientific research communication, and at the same time, mark institutions in Hong Kong and Macau in the another major breakthrough and progress of Greater Bay Area, and carried out drug the Group in the area of biomedicine. molecular screening, process research and development, clinical trials, application for The overall site area of registration, marketing and production, 2 is approximately 2,100 m , of commissioned production, etc. “ The United Bio- Technology ” “ ” The United Bio-Technology The United Bio- Technology Supporting Pharmaceutical Development in the Greater Bay Area R&D Investment and Achievements The Group adheres to innovative research and development, continues to invest a lot of resources, and gradually increases investment in research and development. Investment in research and development during the Year was RMB465 million, representing a year-on-year increase of 36.8%. 3.40 3.68 (RMB million) 2020 2019 4.65 2021 17 Environmental, Social and Governance Report 2021 The United Laboratories International Holdings Limited Investment in R&D